tirzepatide 5mg 0.5 ml Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 Syringes Lilly releases Zepbound® (tirzepatide) single-dose

A clinician may consider medication after ESG for selected patients, particularly when appetite control remains difficult, weight loss slows, or weight regain occurs

ipamorelin is used in research and investigational contexts

For instance, Atsushi Kawase et al

Recognizing the warning signs early is critical

Seek medical advice promptly if you experience : Severe or persistent vomiting : This may lead to dehydration and affect blood glucose control, and could indicate gastroparesis (severe delayed gastric emptying) Severe abdominal pain : Particularly if constant, persistent, or radiating to the back, as GLP-1 receptor agonists carry a small risk of pancreatitis Right upper abdominal pain, fever or jaundice : These may indicate gallbladder problems, which can occur with GLP-1 receptor agonists Signs of dehydration : Including dark urine, dizziness, reduced urination, or extreme thirst Inability to tolerate food or fluids : This affects both nutrition and diabetes management Blood in vomit or stools : This requires immediate medical assessment Symptoms of hypoglycaemia : Particularly if taking Victoza alongside sulfonylureas or insulin For urgent concerns, contact NHS 111 or attend your local A&E department if symptoms are severe

Considerations: Can be effective but may cause side effects such as dry mouth, constipation, tingling, and mood changes